Charles & Colvard LTD
Market Movers (8-K)
Charles & Colvard, Ltd. has filed its monthly operating report for June 2026, detailing its financial activities and progress in its Chapter 11 bankruptcy case.
Worse than expected
Capital raise
Charles & Colvard, Ltd. has filed its monthly operating report for May 2026, detailing its financial activities and Chapter 11 proceedings, including a cash loss for the period.
Worse than expected
Capital raise
Charles & Colvard, Ltd. has finalized the sale of its assets to AJS Creations, Inc. for $2.7 million, concluding its Chapter 11 bankruptcy proceedings.
Charles & Colvard, Ltd. has entered into an agreement to sell its assets to AJS Creations, Inc. for $2.7 million following a court-approved auction.
Better than expected
Charles & Colvard secures court approval for stalking horse bidder in its ongoing Chapter 11 bankruptcy proceedings.
Charles & Colvard has entered into an asset purchase agreement with Van Lang Jewelry LLC as part of its ongoing Chapter 11 bankruptcy proceedings.
Quarterly Earnings (10-Q)
Charles & Colvard, a lab-grown gemstone company, reported significant sales declines and net losses, leading to substantial doubt about its ability to continue as a going concern.
Worse than expected
Capital raise
Delay expected
Charles & Colvard, a lab-created gemstone company, reported a significant decline in net sales for the quarter and six months ended December 31, 2024, alongside ongoing concerns about its ability to continue as a going concern.
Worse than expected
Capital raise
Delay expected
Charles & Colvard, Ltd. reports a 35% decline in net sales and ongoing losses, raising substantial doubt about its ability to continue as a going concern.
Delay expected
Worse than expected
Capital raise
10-Q: Charles & Colvard Reports Q3 2024 Results Amidst Economic Headwinds and Going Concern Uncertainty
Charles & Colvard's Q3 2024 results reveal a significant net loss and decreased sales, raising substantial doubt about the company's ability to continue as a going concern.
Worse than expected
Capital raise
Charles & Colvard experienced a significant decrease in net sales and a widening net loss in the second quarter of fiscal year 2024 compared to the same period last year.
Worse than expected
Capital raise
Annual Reports (10-K)
Charles & Colvard reports a decrease in net sales for fiscal year 2024 amid economic challenges, while focusing on operational efficiency and strategic initiatives.
Delay expected
Capital raise
Worse than expected
Insider Trading (Form 4)
Charles & Colvard Director Neal Goldman was granted 24,000 restricted stock units under the Fiscal 2026 Executive Incentive Program.
Charles & Colvard Director James Tu received a grant of 480,000 restricted stock units under the Fiscal 2026 Executive Incentive Program.
Charles & Colvard Director Anne M. Butler was granted 24,000 restricted stock units as part of the company's Fiscal 2026 Executive Incentive Program.
Charles & Colvard's President and CEO, Don O'Connell, received a restricted stock award of 240,000 shares as part of the Fiscal 2026 Executive Incentive Program.
Charles & Colvard Ltd. Director Ruten Bhanderi was granted 240,000 restricted stock units under the Fiscal 2026 Executive Incentive Program.
Charles & Colvard's CFO, Clint J. Pete, received a significant restricted stock award of 102,000 shares, aligning executive incentives with long-term company performance.
Proxy Statements (Def-14A)
Activist investor Riverstyx Capital Management is soliciting proxies to elect four nominees to Charles & Colvard's board, citing poor financial discipline and dilutive stock issuances.
Delay expected
Capital raise
A North Carolina Business Court Order mandates Charles & Colvard to hold its 2025 Annual Shareholder Meeting on October 13, 2025, following an application by shareholder RiverStyx Fund, LP.
Worse than expected
Delay expected
Charles & Colvard has invalidated Riverstyx Capital Management's director nominations for its upcoming Annual Meeting due to non-compliance with the company's bylaws.
DEF 14A: Charles & Colvard Seeks Shareholder Approval for Reverse Stock Split to Regain Nasdaq Compliance
Charles & Colvard is asking shareholders to approve a reverse stock split to increase its share price and regain compliance with Nasdaq's minimum bid price requirement.
Schedule 13D - Activist Investments
Duc Pham and a newly formed group, holding 11.9% of Charles & Colvard, plan to nominate a director slate for the 2025 annual meeting.
SCHEDULE 13D/A: Activist Group Challenges Charles & Colvard Board
A group of investors, led by Duc Pham and Riverstyx Capital, has formed to challenge Charles & Colvard's board, citing concerns over company trajectory, dilutive financing, and seeking board representation.
Worse than expected
Ethara Capital LLC has significantly increased its ownership in Charles & Colvard LTD to 42.79% through a convertible note conversion and irrevocable voting proxies.
Capital raise
Riverstyx Capital Management and affiliates have nominated three directors for election to Charles & Colvard's board, signaling a push for strategic changes.
Activist investor Duc Pham has nominated himself for election to the board of directors of Charles & Colvard Ltd. and intends to solicit proxies for the 2025 annual meeting.
Riverstyx Fund, LP, an activist investor, has nominated three individuals, including Ben Franklin, for election to Charles & Colvard Ltd.'s Board of Directors at the 2025 annual meeting.